U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07015411) titled 'Neuro-Complex & Multi Supplements for Migraine Prevention' on May 19.
Brief Summary: The goal of this prospective, monocentric, open-label, non-randomized and single arm study is to evaluate a reduction of migraine days per months (MDM) by 25% by using the combined supplementation with Neuro-Complex & Multi after 8 weeks of product intake on participants with diagnosis of migraine meeting the criteria of the International Classification of Headache Disorders (ICHD-3) (with or without aura).
The main endpoint of this clinical trial is :
The mean changes in migraine days per month (MDM) after 8 weeks of supplementation.
Participant...